e-ISSN: Pending
Negative / Null Result ReportOpen accessEngineering· cited by 9

Pulsatile sequential drug release system for cascade tumor deep penetration and differentiation therapy to enhance chemoimmunotherapy

Fengxiang Liu; Shipeng Ning; Xia Wang; Xiaoyuan Fan; Bin Wan; Fei Sun; Lili Du; Ke Shi · 2025 · Science Advances

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Cancer stem cells (CSCs) and myeloid-derived suppressor cells (MDSCs) contribute to chemoresistance and immunosuppression, constraining chemoimmunotherapy outcomes. Differentiation therapy, aiming to mature CSCs and MDSCs, shows great promise. However, its efficacy is hindered by limited accessibility in hypoxic deep tumor regions. Inspired by the apoptotic body (ApoBD)-mediated deep tumor penetration, we design a pulsatile sequential drug release system with a core-shell structure. The reversible acid-responsive shell protonates and swells in lysosomes to release doxorubicin, inducing lysosom

Abstract by Fengxiang Liu; Shipeng Ning; Xia Wang; Xiaoyuan Fan; Bin Wan; Fei Sun; Lili Du; Ke Shi, Science Advances (2025) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1126/sciadv.adr8001